← Open Payments lookup

MELISSA MOLINA-MADRID: Open Payments

NPI 1093366486 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$374 in 18 payments from 10 companies in 2025. Trend: 2023 $185 · 2024 $94 · 2025 $374

Food & beverage: $374
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$89
ABBVIE INC.3$57
Vanda Pharmaceuticals Inc.3$53
Janssen Pharmaceuticals, Inc2$40
Axsome Therapeutics, Inc.1$28
Luye Pharma (USA) Ltd.1$26
Tris Pharma Inc1$24
E.R. Squibb & Sons, L.L.C.1$21
Otsuka America Pharmaceutical, Inc.1$20
Teva Pharmaceuticals USA, Inc.1$16

Products named: INGREZZA, VRAYLAR, FANAPT, Auvelity, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, Dyanavel XR, COBENFY.

Industry payments across FL — which companies pay providers there.